Intercept Pharmaceuticals

Developer of therapeutics to treat progressive non-viral liver diseases

placeNew York City, New York, United States calendar_todayFounded 2002 groups341 employees language interceptpharma.com

Registered entities

Investor mix

9 investors on record; lead investors include Orbimed; 2 have since exited.

Investor typeCountShare
Venture capital333%
Private equity444%
Other / undisclosed222%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

8 Jun 2025 · Medical Science Liaison, Great Plains West · Denver

1 May 2025 · Medical Science Liaison, Northeast · Boston

27 Mar 2025 · Director Reimbursement · null

5 Mar 2025 · Medical Science Liaison, Great Plains · Denver

Based on job postings tracked across public sources.

Coming soon